High-Grade Soft Tissue Sarcoma: Ifosfamide and Doxorubicin Study

We are studying a combination of chemotherapy drugs for patients with localized high-grade soft tissue sarcoma. The goal is to see how well this treatment works and to understand its safety and impact on quality of life.

Efficacy phase (II)No PlaceboStandard MedicinesInjectionOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Adriamycin
Adriamycin is a chemotherapy medicine used to treat many types of cancer.
Holoxan

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Doxorubicin Hydrochloride
Doxorubicin hydrochloride is a chemotherapy substance used to treat various cancers by killing or slowing the growth of cancer cells.
Ifosfamide
Ifosfamide is a chemotherapy substance used to treat various cancers by damaging rapidly dividing tumor cells.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Adriacept Blasen-Instillations-Set
Adriblastin
Adriblastina

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Helse Bergen HF
Department of caner Treatment and Medical Physics
Bergen, Norway
Oslo University Hospital HF
Department of Oncology
Oslo, Norway
Sponsor: Oslo University Hospital HF
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.